Related Experiment Video
Updated: Apr 14, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Breath Holding Spells in Children with Long QT Syndrome
Jeffrey A Robinson1, J Martijn Bos1,2, Susan P Etheridge3
1Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minn, USA.
Insights
Breath holding spells (BHS) in children with Long QT syndrome (LQTS) are rare, occurring in 4.3% of cases, primarily in LQT1. While not frequent, BHS can be the initial symptom of LQTS, necessitating careful evaluation.
Area of Science:
- Pediatric Cardiology
- Clinical Genetics
- Cardiac Electrophysiology
Background:
- Long QT syndrome (LQTS) is a genetic heart disorder.
- Breath holding spells (BHS) are common in children.
- Anecdotal evidence suggests a link between BHS and LQTS.
Purpose of the Study:
- To determine the frequency of BHS in children diagnosed with LQTS.
- To investigate BHS as a presenting symptom in pediatric LQTS.
Main Methods:
- Retrospective review of 115 children diagnosed with LQTS at ≤5 years old.
- Analysis of clinical presentation, LQTS symptoms, diagnostic tests, and treatments.
- Follow-up duration averaged 6.4 years.
Main Results:
- 4.3% of LQTS patients (5/115) experienced BHS.
- All BHS cases occurred in patients with LQT1 (48% of cohort).
- BHS presented as the initial symptom in 4.3% of symptomatic patients.
Conclusions:
- BHS in children with LQTS are relatively rare.
- BHS can be the presenting symptom of LQTS.
- Distinguishing BHS from LQTS-triggered events is crucial for timely treatment.
Background:
Long QT syndrome (LQTS) is a genetic heart rhythm disorder that may present with syncope, seizures, or sudden cardiac death. Breath holding spells (BHS) occur in 5% of all children and have been noted in children with LQTS anecdotally. The purpose of this study was to determine the frequency of BHS in children diagnosed with LQTS at ≤5 years of age.
Design:
A retrospective review was performed to identify children diagnosed with LQTS who were ≤5 years old at initial presentation to our LQTS clinic from August 1999 to November 2013. The mean length of follow-up was 6.4 ± 2.8 years. The electronic medical records were reviewed for clinical presentation of BHS, as well as LQTS-associated symptoms, diagnostic tests, and treatment.
Results:
The study cohort consisted of 115 children with LQTS (58% male; median age at diagnosis, 11 months [range, birth to 5 years]; mean corrected QT interval (QTc), 478 ± 60 milliseconds). At presentation, 80% of patients were asymptomatic. Genetic testing revealed type 1 LQTS (LQT1) in 48%. Overall, 5 of 115 patients (4.3%) had BHS (2 of 5 [40%] male, mean QTc: 492 ± 14 milliseconds, 4 [80%] with family history of LQTS). BHS were the presenting symptom in 1 of 23 symptomatic patients (4.3%). All BHS occurred in patients with LQT1 (P = .02).
Conclusions:
Although BHS among children with LQTS are relatively rare and occur at similar frequency as the general population, they can be the presenting symptom for a heart rhythm disorder. Careful attention to BHS is important to distinguish an innocent BHS from a potential LQTS-triggered cardiac event so that proper treatment is initiated.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Breathing
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias

